These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 2843183
1. [Leu13-psi(CH2NH)Leu14]bombesin is a specific bombesin receptor antagonist in Swiss 3T3 cells. Woll PJ, Coy DH, Rozengurt E. Biochem Biophys Res Commun; 1988 Aug 30; 155(1):359-65. PubMed ID: 2843183 [Abstract] [Full Text] [Related]
2. Biological effects and receptor binding affinities of new pseudononapeptide bombesin/GRP receptor antagonists with N-terminal D-Trp or D-Tpi. Radulovic S, Cai RZ, Serfozo P, Groot K, Redding TW, Pinski J, Schally AV. Int J Pept Protein Res; 1991 Dec 30; 38(6):593-600. PubMed ID: 1726427 [Abstract] [Full Text] [Related]
3. Short-chain pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and Swiss 3T3 cells display strong antimitotic activity. Coy DH, Taylor JE, Jiang NY, Kim SH, Wang LH, Huang SC, Moreau JP, Gardner JD, Jensen RT. J Biol Chem; 1989 Sep 05; 264(25):14691-7. PubMed ID: 2475489 [Abstract] [Full Text] [Related]
4. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects. Narayan S, Spindel ER, Rubin NH, Singh P. Cell Growth Differ; 1992 Feb 05; 3(2):111-8. PubMed ID: 1323998 [Abstract] [Full Text] [Related]
5. Chronic desensitization to bombesin by progressive down-regulation of bombesin receptors in Swiss 3T3 cells. Distinction from acute desensitization. Millar JB, Rozengurt E. J Biol Chem; 1990 Jul 15; 265(20):12052-8. PubMed ID: 2164025 [Abstract] [Full Text] [Related]
6. Conveyance of partial agonism/antagonism to bombesin/gastrin-releasing peptide analogues on Swiss 3T3 cells by a carboxyl-terminal leucine insertion. Kull FC, Leban JJ, Landavazo A, Stewart KD, Stockstill B, McDermed JD. J Biol Chem; 1992 Oct 15; 267(29):21132-8. PubMed ID: 1400423 [Abstract] [Full Text] [Related]
7. Partial agonist activity of the bombesin-receptor antagonist [Leu14-psi-CH2-NH-Leu13]-bombesin in frog peptic cells. Dickinson KE, Uemura N, Sekar MC, McDaniel HB, Anderson W, Coy DH, Hirschowitz BI. Biochem Biophys Res Commun; 1988 Dec 30; 157(3):1154-8. PubMed ID: 2462868 [Abstract] [Full Text] [Related]
8. Arachidonic acid release by bombesin. A novel postreceptor target for heterologous mitogenic desensitization. Millar JB, Rozengurt E. J Biol Chem; 1990 Nov 15; 265(32):19973-9. PubMed ID: 2174059 [Abstract] [Full Text] [Related]
9. Two classes of antagonist interact with receptors for the mitogenic neuropeptides bombesin, bradykinin, and vasopressin. Woll PJ, Rozengurt E. Growth Factors; 1988 Nov 15; 1(1):75-83. PubMed ID: 2483337 [Abstract] [Full Text] [Related]
10. Effect of bombesin, gastrin-releasing peptide (GRP)(14-27) and bombesin/GRP receptor antagonist RC-3095 on growth of nitrosamine-induced pancreatic cancers in hamsters. Szepeshazi K, Schally AV, Groot K, Halmos G. Int J Cancer; 1993 May 08; 54(2):282-9. PubMed ID: 8387464 [Abstract] [Full Text] [Related]
11. A novel bombesin receptor antagonist inhibits autocrine signals in a small cell lung carcinoma cell line. Trepel JB, Moyer JD, Cuttitta F, Frucht H, Coy DH, Natale RB, Mulshine JL, Jensen RT, Sausville EA. Biochem Biophys Res Commun; 1988 Nov 15; 156(3):1383-9. PubMed ID: 2847733 [Abstract] [Full Text] [Related]
12. Identification of the neurotransmitter/neuromodulator functions of the neuropeptide gastrin-releasing peptide in the porcine antrum, using the antagonist (Leu13-psi-CH2 NH-Leu14)-bombesin. Holst JJ, Harling H, Messell T, Coy DH. Scand J Gastroenterol; 1990 Jan 15; 25(1):89-96. PubMed ID: 1968286 [Abstract] [Full Text] [Related]
13. Effects of BIM26226, a potent and specific bombesin receptor antagonist, on amylase release and binding of bombesin-like peptides to AR4-2J cells. Dietrich JB, Hildebrand P, Jeker LB, Pansky A, Eberle AN, Beglinger C. Regul Pept; 1994 Oct 21; 53(3):165-73. PubMed ID: 7531356 [Abstract] [Full Text] [Related]
14. Endocrine effects of new bombesin/gastrin-releasing peptide antagonists in rats. Pinski J, Yano T, Groot K, Cai RZ, Radulovic S, Schally AV. Am J Physiol; 1992 Oct 21; 263(4 Pt 1):E712-7. PubMed ID: 1415689 [Abstract] [Full Text] [Related]
15. Effect of the bombesin receptor blockers [Leu13, psi CH2NH-Leu14]bombesin and N-pivaloyl GRP(20-25) alkylamide (L 686,095-001C002) on basal and neuromedin C-stimulated PRL and GH release in pituitary cell aggregates. Houben H, Denef C. Peptides; 1991 Oct 21; 12(2):371-4. PubMed ID: 1648716 [Abstract] [Full Text] [Related]
16. Probing peptide backbone function in bombesin. A reduced peptide bond analogue with potent and specific receptor antagonist activity. Coy DH, Heinz-Erian P, Jiang NY, Sasaki Y, Taylor J, Moreau JP, Wolfrey WT, Gardner JD, Jensen RT. J Biol Chem; 1988 Apr 15; 263(11):5056-60. PubMed ID: 2451661 [Abstract] [Full Text] [Related]
17. Functional expression of bombesin receptor in most adult and pediatric human glioblastoma cell lines; role in mitogenesis and in stimulating the mitogen-activated protein kinase pathway. Sharif TR, Luo W, Sharif M. Mol Cell Endocrinol; 1997 Jun 20; 130(1-2):119-30. PubMed ID: 9220028 [Abstract] [Full Text] [Related]
18. Bombesin receptors in a human duodenal tumor cell line: binding properties and function. Williams BY, Schonbrunn A. Cancer Res; 1994 Feb 01; 54(3):818-24. PubMed ID: 8306345 [Abstract] [Full Text] [Related]